|
XPOT expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.423400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.343000E-01 |
| Normal-vs-Stage2 |
6.679800E-02 |
| Normal-vs-Stage3 |
8.661700E-03 |
| Normal-vs-Stage4 |
3.362400E-01 |
| Stage1-vs-Stage2 |
6.058100E-02 |
| Stage1-vs-Stage3 |
3.130400E-02 |
| Stage1-vs-Stage4 |
4.930600E-01 |
| Stage2-vs-Stage3 |
5.779000E-03 |
| Stage2-vs-Stage4 |
3.130100E-02 |
| Stage3-vs-Stage4 |
5.091600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.225640E-01 |
| Normal-vs-AfricanAmerican |
6.116900E-03 |
| Normal-vs-Asian |
5.173400E-01 |
| Caucasian-vs-AfricanAmerican |
1.190600E-01 |
| Caucasian-vs-Asian |
8.282200E-01 |
| AfricanAmerican-vs-Asian |
2.133200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.819800E-02 |
| Normal-vs-Female |
7.965600E-01 |
| Male-vs-Female |
4.450000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.649800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.300000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.075800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.277880E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.992400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.027400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.181600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.207600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.131170E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.898500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.539900E-02 |
| Classical-VS-Follicular |
2.796300E-03 |
| Classical-VS-Other |
3.315300E-03 |
| Classical-VS-Normal |
1.590200E-01 |
| Tall-VS-Follicular |
2.194400E-04 |
| Tall-VS-Other |
2.662200E-01 |
| Tall-VS-Normal |
4.138500E-03 |
| Follicular-VS-Other |
4.12640000002629E-06 |
| Follicular-VS-Normal |
1.675630E-02 |
| Other-VS-Normal |
1.781080E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.393600E-01 |
| Normal-vs-N1 |
7.722200E-02 |
| N0-vs-N1 |
4.547700E-02 |
|
|
